In the latest session, Verve Therapeutics Inc (NASDAQ: VERV) closed at $8.52 down -1.84% from its previous closing price of $8.68. In other words, the price has decreased by -$0.16 from its previous closing price. On the day, 1384559 shares were traded.
Ratios:
For a deeper understanding of Verve Therapeutics Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 17.24 and its Current Ratio is at 17.24. In the meantime, Its Debt-to-Equity ratio is 0.12 whereas as Long-Term Debt/Eq ratio is at 0.11.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Canaccord Genuity on April 13, 2023, initiated with a Buy rating and assigned the stock a target price of $29.
On February 01, 2023, Cantor Fitzgerald started tracking the stock assigning a Neutral rating and target price of $21.
On December 15, 2022, Goldman started tracking the stock assigning a Sell rating and target price of $13.Goldman initiated its Sell rating on December 15, 2022, with a $13 target price.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Apr 02 ’24 when Nickerson Joan sold 1,514 shares for $8.24 per share. The transaction valued at 12,475 led to the insider holds 8,659 shares of the business.
Dorval Allison sold 554 shares of VERV for $6,343 on Nov 29 ’23. The Chief Financial Officer now owns 4,060 shares after completing the transaction at $11.45 per share.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, VERV now has a Market Capitalization of 712.44M and an Enterprise Value of 163.39M. For the stock, the TTM Price-to-Sale (P/S) ratio is 56.91 while its Price-to-Book (P/B) ratio in mrq is 1.16. Its current Enterprise Value per Revenue stands at 13.90 whereas that against EBITDA is -0.75.
Stock Price History:
Over the past 52 weeks, VERV has reached a high of $21.42, while it has fallen to a 52-week low of $7.36. The 50-Day Moving Average of the stock is 12.99, while the 200-Day Moving Average is calculated to be 14.01.
Shares Statistics:
For the past three months, VERV has traded an average of 1.26M shares per day and 1.97M over the past ten days. A total of 81.97M shares are outstanding, with a floating share count of 54.79M. Insiders hold about 30.25% of the company’s shares, while institutions hold 70.27% stake in the company. Shares short for VERV as of Mar 15, 2024 were 14.1M with a Short Ratio of 11.22, compared to 12.59M on Feb 15, 2024. Therefore, it implies a Short% of Shares Outstanding of 16.87% and a Short% of Float of 21.77%.
Earnings Estimates
There are 8 different market analysts currently analyzing its stock. On average, analysts expect EPS of -$0.73 for the current quarter, with a high estimate of -$0.61 and a low estimate of -$0.83, while EPS last year was -$0.84. The consensus estimate for the next quarter is -$0.74, with high estimates of -$0.6 and low estimates of -$0.85.
Analysts are recommending an EPS of between -$2.44 and -$3.47 for the fiscal current year, implying an average EPS of -$2.98. EPS for the following year is -$3.22, with 8 analysts recommending between -$2.93 and -$3.75.
